Keywords
Last Name
Institution

Barbara Coffey

TitlePROFESSOR
InstitutionMount Sinai
DepartmentPsychiatry
Address1240 Park Avenue
1st FLoor Room 3
New York NY 10029
Phone212-659-1663
Fax212-659-1693

     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Fields J, Lim T, Kolevzon A, Coffey BJ. A rare case of anti-N-methyl-D-aspartate receptor encephalitis in an adolescent. J Child Adolesc Psychopharmacol. 2013 Sep; 23(7):502-6.
      View in: PubMed
    2. Pedraza JD, Coffey B. Obsessive-compulsive disorder and comorbid attention-deficit/hyperactivity disorder: a complex diagnostic disentanglement and treatment. J Child Adolesc Psychopharmacol. 2013 Aug; 23(6):419-22.
      View in: PubMed
    3. Taskiran S, Coffey BJ. Unremitting impulsive aggression in a child with childhood onset schizophrenia and pervasive development disorder-not otherwise specified: the role of stimulants, atypical antipsychotics and mood stabilizers. J Child Adolesc Psychopharmacol. 2013 Jun; 23(5):363-6.
      View in: PubMed
    4. Paul P, Mehta S, Coffey BJ. Anorexia nervosa in a 14-year-old second-generation Hispanic adolescent boy. J Child Adolesc Psychopharmacol. 2013 May; 23(4):295-9.
      View in: PubMed
    5. Samar SM, Moyano MB, Braña-Berríos M, Irazoqui G, Matos A, Kichic R, Gellatly R, Ibanez-Gomez L, Zwilling AL, Petkova E, Coffey BJ. Children and adolescents with Tourette's disorder in the USA versus Argentina: behavioral differences may reflect cultural factors. Eur Child Adolesc Psychiatry. 2013 Nov; 22(11):701-7.
      View in: PubMed
    6. Wilson B, Paul P, Mehta S, Coffey BJ. Hypokalemia secondary to bupropion sustained release overdose. J Child Adolesc Psychopharmacol. 2013 Feb; 23(1):57-60.
      View in: PubMed
    7. Gibbs T, Tan A, Weis RJ, Coffey BJ. Stimulant medication addition to antidepressant in an adolescent with difficult to treat depression. J Child Adolesc Psychopharmacol. 2012 Dec; 22(6):466-9.
      View in: PubMed
    8. Nooner KB, Colcombe SJ, Tobe RH, Mennes M, Benedict MM, Moreno AL, Panek LJ, Brown S, Zavitz ST, Li Q, Sikka S, Gutman D, Bangaru S, Schlachter RT, Kamiel SM, Anwar AR, Hinz CM, Kaplan MS, Rachlin AB, Adelsberg S, Cheung B, Khanuja R, Yan C, Craddock CC, Calhoun V, Courtney W, King M, Wood D, Cox CL, Kelly AM, Di Martino A, Petkova E, Reiss PT, Duan N, Thomsen D, Biswal B, Coffey B, Hoptman MJ, Javitt DC, Pomara N, Sidtis JJ, Koplewicz HS, Castellanos FX, Leventhal BL, Milham MP. The NKI-Rockland Sample: A Model for Accelerating the Pace of Discovery Science in Psychiatry. Front Neurosci. 2012; 6:152.
      View in: PubMed
    9. Isa A, Miles J, Emslie G, Coffey BJ. Depression pharmacotherapy in an adolescent with Hodgkin's lymphoma. J Child Adolesc Psychopharmacol. 2012 Aug; 22(4):316-9.
      View in: PubMed
    10. Singh G, Coffey BJ. Sexual obsessions, compulsions, suicidality and homicidality in an adolescent diagnosed with bipolar disorder not otherwise specified, obsessive-compulsive disorder, pervasive developmental disorder not otherwise specified, and mild mental retardation. J Child Adolesc Psychopharmacol. 2012 Jun; 22(3):250-3.
      View in: PubMed
    11. Gabbay V, Babb JS, Klein RG, Panzer AM, Katz Y, Alonso CM, Petkova E, Wang J, Coffey BJ. A double-blind, placebo-controlled trial of ?-3 fatty acids in Tourette's disorder. Pediatrics. 2012 Jun; 129(6):e1493-500.
      View in: PubMed
    12. Lebowitz ER, Motlagh MG, Katsovich L, King RA, Lombroso PJ, Grantz H, Lin H, Bentley MJ, Gilbert DL, Singer HS, Coffey BJ. Tourette syndrome in youth with and without obsessive compulsive disorder and attention deficit hyperactivity disorder. Eur Child Adolesc Psychiatry. 2012 Aug; 21(8):451-7.
      View in: PubMed
    13. Kurlan R, Crespi G, Coffey B, Mueller-Vahl K, Koval S, Wunderlich G. A multicenter randomized placebo-controlled clinical trial of pramipexole for Tourette's syndrome. Mov Disord. 2012 May; 27(6):775-8.
      View in: PubMed
    14. Grody MB, Coffey BJ. Presentation and treatment of acute psychosis in an adolescent girl with cerebral palsy. J Child Adolesc Psychopharmacol. 2012 Apr; 22(2):175-8.
      View in: PubMed
    15. Burkey MD, Howell C, Riddle MA, Coffey BJ. Antipsychotic-induced psychotic-like syndrome and pathological smiling in an adolescent. J Child Adolesc Psychopharmacol. 2012 Feb; 22(1):92-5.
      View in: PubMed
    16. Jadhav S, Coffey BJ. Drug-induced movement disorders and Syndenham's chorea in an antipsychotic-treated young child. J Child Adolesc Psychopharmacol. 2011 Oct; 21(5):487-90.
      View in: PubMed
    17. Braña-Berríos M, Lam K, Coffey B. Dysphoria associated with neuroleptic withdrawal in an adolescent with Tourette's disorder. J Child Adolesc Psychopharmacol. 2011 Aug; 21(4):371-4.
      View in: PubMed
    18. Freedman JL, Ryan CA, Coffey BJ. Olanzapine-induced agranulocytosis in an adolescent male with psychosis. J Child Adolesc Psychopharmacol. 2011 Apr; 21(2):185-9.
      View in: PubMed
    19. Kaur T, Dobroshi Z, McCarthy J, Coffey BJ. New onset of psychotic symptoms in an adolescent with pervasive developmental disorder, not otherwise specified. J Child Adolesc Psychopharmacol. 2011 Feb; 21(1):87-90.
      View in: PubMed
    20. Leckman JF, King RA, Gilbert DL, Coffey BJ, Singer HS, Dure LS, Grantz H, Katsovich L, Lin H, Lombroso PJ, Kawikova I, Johnson DR, Kurlan RM, Kaplan EL. Streptococcal upper respiratory tract infections and exacerbations of tic and obsessive-compulsive symptoms: a prospective longitudinal study. J Am Acad Child Adolesc Psychiatry. 2011 Feb; 50(2):108-118.e3.
      View in: PubMed
    21. Bobb VT, Jarskog LF, Coffey BJ. Adolescent with treatment-refractory schizophrenia and clozapine-induced cardiomyopathy managed with high-dose olanzapine. J Child Adolesc Psychopharmacol. 2010 Dec; 20(6):539-43.
      View in: PubMed
    22. Young L, Coffey BJ. Bipolar disorder and valproate-induced hyperammonemic encephalopathy in an adolescent with diabetes. J Child Adolesc Psychopharmacol. 2010 Oct; 20(5):449-52.
      View in: PubMed
    23. Saranga V, Coffey BJ. Bipolar disorder or substance-induced mood disorder in an adolescent? J Child Adolesc Psychopharmacol. 2010 Aug; 20(4):343-6.
      View in: PubMed
    24. Coffey BJ, Rapoport J. Obsessive-compulsive disorder and Tourette's disorder: where are we now? J Child Adolesc Psychopharmacol. 2010 Aug; 20(4):235-6.
      View in: PubMed
    25. Lyon GJ, Samar SM, Conelea C, Trujillo MR, Lipinski CM, Bauer CC, Brandt BC, Kemp JJ, Lawrence ZE, Howard J, Castellanos FX, Woods D, Coffey BJ. Testing tic suppression: comparing the effects of dexmethylphenidate to no medication in children and adolescents with attention-deficit/hyperactivity disorder and Tourette's disorder. J Child Adolesc Psychopharmacol. 2010 Aug; 20(4):283-9.
      View in: PubMed
    26. Lyon GJ, Shprecher D, Coffey B, Kurlan R. Tourette's Disorder. Curr Treat Options Neurol. 2010 Jul; 12(4):274-86.
      View in: PubMed
    27. Roberts E, Rostain AL, Samar S, Coffey BJ. Obsessional and atypical tic symptoms in an adolescent with complex Tourette's disorder and atypical pervasive developmental disorder not otherwise specified. J Child Adolesc Psychopharmacol. 2010 Jun; 20(3):219-23.
      View in: PubMed
    28. Weaver LA, De León DD, Borgmann-Winter K, Coffey BJ. Use of metformin to control clozapine-associated weight gain in an adolescent with schizoaffective disorder. J Child Adolesc Psychopharmacol. 2010 Apr; 20(2):153-7.
      View in: PubMed
    29. Nass R, Coffey BJ. Compulsive spitting in a child with pervasive developmental disorder and Tourette's disorder: tic or compulsion? J Child Adolesc Psychopharmacol. 2010 Feb; 20(1):71-3.
      View in: PubMed
    30. Zinner SH, Coffey BJ. Developmental and behavioral disorders grown up: Tourette's disorder. J Dev Behav Pediatr. 2009 Dec; 30(6):560-73.
      View in: PubMed
    31. Lyon GJ, Samar S, Jummani R, Hirsch S, Spirgel A, Goldman R, Coffey BJ. Aripiprazole in children and adolescents with Tourette's disorder: an open-label safety and tolerability study. J Child Adolesc Psychopharmacol. 2009 Dec; 19(6):623-33.
      View in: PubMed
    32. Jummani R, Coffey BJ. Hyperprolactinemia in an adolescent with psychotic disorder on risperidone. J Child Adolesc Psychopharmacol. 2009 Dec; 19(6):791-4.
      View in: PubMed
    33. Schwartz SJ, Sharma KC, Coffey BJ. Executive function deficits, attention-deficit/hyperactivity disorder, tics, and obsessive-compulsive disorder in an adolescent. J Child Adolesc Psychopharmacol. 2009 Oct; 19(5):585-8.
      View in: PubMed
    34. Brent DA, Greenhill LL, Compton S, Emslie G, Wells K, Walkup JT, Vitiello B, Bukstein O, Stanley B, Posner K, Kennard BD, Cwik MF, Wagner A, Coffey B, March JS, Riddle M, Goldstein T, Curry J, Barnett S, Capasso L, Zelazny J, Hughes J, Shen S, Gugga SS, Turner JB. The Treatment of Adolescent Suicide Attempters study (TASA): predictors of suicidal events in an open treatment trial. J Am Acad Child Adolesc Psychiatry. 2009 Oct; 48(10):987-96.
      View in: PubMed
    35. Vitiello B, Brent DA, Greenhill LL, Emslie G, Wells K, Walkup JT, Stanley B, Bukstein O, Kennard BD, Compton S, Coffey B, Cwik MF, Posner K, Wagner A, March JS, Riddle M, Goldstein T, Curry J, Capasso L, Mayes T, Shen S, Gugga SS, Turner JB, Barnett S, Zelazny J. Depressive symptoms and clinical status during the Treatment of Adolescent Suicide Attempters (TASA) Study. J Am Acad Child Adolesc Psychiatry. 2009 Oct; 48(10):997-1004.
      View in: PubMed
    36. Lyon GJ, Coffey BJ. Complex tics and complex management in a case of severe Tourette's disorder (TD) in an adolescent. J Child Adolesc Psychopharmacol. 2009 Aug; 19(4):469-74.
      View in: PubMed
    37. Hulvershorn LA, Madou MR, Weis JR, Coffey B. First-episode psychosis in an adolescent with seizure disorder and Tetralogy of Fallot. J Child Adolesc Psychopharmacol. 2009 Jun; 19(3):307-11.
      View in: PubMed
    38. Gabbay V, Coffey BJ, Guttman LE, Gottlieb L, Katz Y, Babb JS, Hamamoto MM, Gonzalez CJ. A cytokine study in children and adolescents with Tourette's disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Aug 31; 33(6):967-71.
      View in: PubMed
    39. Davis GP, McCarthy JT, Magill DB, Coffey B. Behavioral effects of levetiracetam mitigated by pyridoxine. J Child Adolesc Psychopharmacol. 2009 Apr; 19(2):209-11.
      View in: PubMed
    40. Quigley J, Lommel KM, Coffey B. Catatonia in an adolescent with Asperger's disorder. J Child Adolesc Psychopharmacol. 2009 Feb; 19(1):93-6.
      View in: PubMed
    41. Lyon GJ, Coffey B, Silva R. Postraumatic stress disorder and reactive attachment disorder: outcome in an adolescent. J Child Adolesc Psychopharmacol. 2008 Dec; 18(6):641-6.
      View in: PubMed
    42. Budman C, Coffey BJ, Shechter R, Schrock M, Wieland N, Spirgel A, Simon E. Aripiprazole in children and adolescents with Tourette disorder with and without explosive outbursts. J Child Adolesc Psychopharmacol. 2008 Oct; 18(5):509-15.
      View in: PubMed
    43. Groff K, Coffey BJ. Psychosis or atypical neuroleptic malignant syndrome in an adolescent? J Child Adolesc Psychopharmacol. 2008 Oct; 18(5):529-32.
      View in: PubMed
    44. Miriyala K, Coffey B. Renal failure in a depressed adolescent on escitalopram. J Child Adolesc Psychopharmacol. 2008 Aug; 18(4):405-8.
      View in: PubMed
    45. Gabbay V, Coffey BJ, Babb JS, Meyer L, Wachtel C, Anam S, Rabinovitz B. Pediatric autoimmune neuropsychiatric disorders associated with streptococcus: comparison of diagnosis and treatment in the community and at a specialty clinic. Pediatrics. 2008 Aug; 122(2):273-8.
      View in: PubMed
    46. Spindel C, Gabbay V, Coffey B. Adolescent major depression: challenges to treatment. J Child Adolesc Psychopharmacol. 2008 Jun; 18(3):293-6.
      View in: PubMed
    47. Rais AR, Kimmel S, Shrestha N, Rais TB, Coffey BJ. Atypical neuroleptic malignant syndrome in an adolescent. J Child Adolesc Psychopharmacol. 2008 Apr; 18(2):215-20.
      View in: PubMed
    48. Kuluva J, Hirsch S, Coffey B. PANDAS and paroxysms: a case of conversion disorder? J Child Adolesc Psychopharmacol. 2008 Feb; 18(1):109-15.
      View in: PubMed
    49. Delgado SV, Saldaña SN, Barzman DH, Coffey B. Response to duloxetine in a depressed, treatment-resistant adolescent female. J Child Adolesc Psychopharmacol. 2007 Dec; 17(6):889-94.
      View in: PubMed
    50. Spencer TJ, Sallee FR, Gilbert DL, Dunn DW, McCracken JT, Coffey BJ, Budman CL, Ricardi RK, Leonard HL, Allen AJ, Milton DR, Feldman PD, Kelsey DK, Geller DA, Linder SL, Lewis DW, Winner PK, Kurlan RM, Mintz M. Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome. J Atten Disord. 2008 Jan; 11(4):470-81.
      View in: PubMed
    51. Williams DT, Hirsch S, Coffey B. Mood and anxiety symptoms in an adolescent with Pervasive Developmental Disorder Not Otherwise Specified and moderate mental retardation. J Child Adolesc Psychopharmacol. 2007 Oct; 17(5):721-6.
      View in: PubMed
    52. Coffey B, Wieland N. Tics, anxiety, and possible PANDAS in an adolescent. J Child Adolesc Psychopharmacol. 2007 Aug; 17(4):533-8.
      View in: PubMed
    53. Anam S, Jummani R, Coffey B, Wieland N. Treatment of juvenile-onset bipolar disorder in a child with Turner's syndrome. J Child Adolesc Psychopharmacol. 2007 Jun; 17(3):384-90.
      View in: PubMed
    54. Gutkovich ZA, Carlson GA, Carlson HE, Coffey B, Wieland N. Asperger's disorder and co-morbid bipolar disorder: diagnostic and treatment challenges. J Child Adolesc Psychopharmacol. 2007 Apr; 17(2):247-55.
      View in: PubMed
    55. Kotcher L, Wieland N, Coffey B. Trichotillomania and co-morbid psychiatric disorders in a 10-year-old boy. J Child Adolesc Psychopharmacol. 2007 Feb; 17(1):137-41.
      View in: PubMed
    56. Ivanov I, Klein M, Green WH, Coffey B. The challenges of psychopharmacological management of children with severe developmental disabilities. J Child Adolesc Psychopharmacol. 2006 Dec; 16(6):793-9.
      View in: PubMed
    57. Reinblatt SP, Abanilla PK, Jummani R, Coffey B. Loxapine treatment in an autistic child with aggressive behavior: therapeutic challenges. J Child Adolesc Psychopharmacol. 2006 Oct; 16(5):639-43.
      View in: PubMed
    58. Vito J, Jummani R, Coffey B. Advanced pediatric psychopharmacology. J Child Adolesc Psychopharmacol. 2006 Aug; 16(4):498-502.
      View in: PubMed
    59. Geller DA, Doyle R, Shaw D, Mullin B, Coffey B, Petty C, Vivas F, Biederman J. A quick and reliable screening measure for OCD in youth: reliability and validity of the obsessive compulsive scale of the Child Behavior Checklist. Compr Psychiatry. 2006 May-Jun; 47(3):234-40.
      View in: PubMed
    60. Scahill L, Erenberg G, Berlin CM, Budman C, Coffey BJ, Jankovic J, Kiessling L, King RA, Kurlan R, Lang A, Mink J, Murphy T, Zinner S, Walkup J. Contemporary assessment and pharmacotherapy of Tourette syndrome. NeuroRx. 2006 Apr; 3(2):192-206.
      View in: PubMed
    61. Coffey BJ, Shechter RL. Treatment of co-morbid obsessive compulsive disorder, mood, and anxiety disorders. Adv Neurol. 2006; 99:208-21.
      View in: PubMed
    62. Allen AJ, Kurlan RM, Gilbert DL, Coffey BJ, Linder SL, Lewis DW, Winner PK, Dunn DW, Dure LS, Sallee FR, Milton DR, Mintz MI, Ricardi RK, Erenberg G, Layton LL, Feldman PD, Kelsey DK, Spencer TJ. Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders. Neurology. 2005 Dec 27; 65(12):1941-9.
      View in: PubMed
    63. Budman C, Coffey B, Dure L, Gilbert D, Juncos J, Kaplan E, King R, Kurlan R, Lowe T, Mack K, Mink J, Schlaggar B, Singer H. Regarding "antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders". Biol Psychiatry. 2005 Dec 1; 58(11):917; author reply 918-9.
      View in: PubMed
    64. Coffey BJ, Biederman J, Geller D, Frazier J, Spencer T, Doyle R, Gianini L, Small A, Frisone DF, Magovcevic M, Stein N, Faraone SV. Reexamining Tic persistence and Tic-associated impairment in Tourette's Disorder: findings from a naturalistic follow-up study. J Nerv Ment Dis. 2004 Nov; 192(11):776-80.
      View in: PubMed
    65. Reinblatt SP, Rifkin A, Castellanos FX, Coffey BJ. General psychiatry residents' perceptions of specialized training in the field of mental retardation. Psychiatr Serv. 2004 Mar; 55(3):312-4.
      View in: PubMed
    66. Anandan S, Wigg CL, Thomas CR, Coffey B. Psychosurgery for self-injurious behavior in Tourette's disorder. J Child Adolesc Psychopharmacol. 2004; 14(4):531-8.
      View in: PubMed
    67. Rappaport N, Coffey B. Psychopharmacology in the school setting: therapeutic challenges in an adolescent with attention deficit hyperactivity disorder, possible bipolar disorder, and other comorbidity. J Child Adolesc Psychopharmacol. 2004; 14(1):3-7.
      View in: PubMed
    68. Wilhelm S, Deckersbach T, Coffey BJ, Bohne A, Peterson AL, Baer L. Habit reversal versus supportive psychotherapy for Tourette's disorder: a randomized controlled trial. Am J Psychiatry. 2003 Jun; 160(6):1175-7.
      View in: PubMed
    69. Geller DA, Coffey B, Faraone S, Hagermoser L, Zaman NK, Farrell CL, Mullin B, Biederman J. Does comorbid attention-deficit/hyperactivity disorder impact the clinical expression of pediatric obsessive-compulsive disorder? CNS Spectr. 2003 Apr; 8(4):259-64.
      View in: PubMed
    70. Gabbay V, Coffey B. Obsessive-Compulsive disorder, Tourette's disorder, or pediatric autoimmune neuropsychiatric disorders associated with Streptococcus in an adolescent? Diagnostic and therapeutic challenges. J Child Adolesc Psychopharmacol. 2003; 13(3):209-12.
      View in: PubMed
    71. Coffey B. Clinical case presentation: therapeutic challenges in adolescent-onset bipolar disorder. J Child Adolesc Psychopharmacol. 2003; 13(4):425-30.
      View in: PubMed
    72. Spencer T, Biederman J, Coffey B, Geller D, Crawford M, Bearman SK, Tarazi R, Faraone SV. A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2002 Jul; 59(7):649-56.
      View in: PubMed
    73. Geller DA, Biederman J, Faraone SV, Cradock K, Hagermoser L, Zaman N, Frazier JA, Coffey BJ, Spencer TJ. Attention-deficit/hyperactivity disorder in children and adolescents with obsessive-compulsive disorder: fact or artifact? J Am Acad Child Adolesc Psychiatry. 2002 Jan; 41(1):52-8.
      View in: PubMed
    74. Geller DA, Biederman J, Faraone S, Agranat A, Cradock K, Hagermoser L, Kim G, Frazier J, Coffey BJ. Developmental aspects of obsessive compulsive disorder: findings in children, adolescents, and adults. J Nerv Ment Dis. 2001 Jul; 189(7):471-7.
      View in: PubMed
    75. Geller DA, Biederman J, Faraone SV, Bellordre CA, Kim GS, Hagermoser L, Cradock K, Frazier J, Coffey BJ. Disentangling chronological age from age of onset in children and adolescents with obsessive--compulsive disorder. Int J Neuropsychopharmacol. 2001 Jun; 4(2):169-78.
      View in: PubMed
    76. Spencer TJ, Biederman J, Faraone S, Mick E, Coffey B, Geller D, Kagan J, Bearman SK, Wilens T. Impact of tic disorders on ADHD outcome across the life cycle: findings from a large group of adults with and without ADHD. Am J Psychiatry. 2001 Apr; 158(4):611-7.
      View in: PubMed
    77. Spencer T, Biederman J, Coffey B, Geller D, Faraone S, Wilens T. Tourette disorder and ADHD. Adv Neurol. 2001; 85:57-77.
      View in: PubMed
    78. Rauch SL, Whalen PJ, Curran T, Shin LM, Coffey BJ, Savage CR, McInerney SC, Baer L, Jenike MA. Probing striato-thalamic function in obsessive-compulsive disorder and Tourette syndrome using neuroimaging methods. Adv Neurol. 2001; 85:207-24.
      View in: PubMed
    79. Coffey BJ, Biederman J, Geller DA, Spencer T, Park KS, Shapiro SJ, Garfield SB. The course of Tourette's disorder: a literature review. Harv Rev Psychiatry. 2000 Oct; 8(4):192-8.
      View in: PubMed
    80. Coffey BJ, Biederman J, Spencer T, Geller DA, Faraone SV, Bellordre CA. Informativeness of structured diagnostic interviews in the identification of Tourette's disorder in referred youth. J Nerv Ment Dis. 2000 Sep; 188(9):583-8.
      View in: PubMed
    81. Coffey BJ, Biederman J, Geller DA, Spencer TJ, Kim GS, Bellordre CA, Frazier JA, Cradock K, Magovcevic M. Distinguishing illness severity from tic severity in children and adolescents with Tourette's disorder. J Am Acad Child Adolesc Psychiatry. 2000 May; 39(5):556-61.
      View in: PubMed
    82. Coffey BJ, Biederman J, Smoller JW, Geller DA, Sarin P, Schwartz S, Kim GS. Anxiety disorders and tic severity in juveniles with Tourette's disorder. J Am Acad Child Adolesc Psychiatry. 2000 May; 39(5):562-8.
      View in: PubMed
    83. Miguel EC, do Rosário-Campos MC, Prado HS, do Valle R, Rauch SL, Coffey BJ, Baer L, Savage CR, O'Sullivan RL, Jenike MA, Leckman JF. Sensory phenomena in obsessive-compulsive disorder and Tourette's disorder. J Clin Psychiatry. 2000 Feb; 61(2):150-6; quiz 157.
      View in: PubMed
    84. Geller D, Biederman J, Faraone SV, Frazier J, Coffey BJ, Kim G, Bellordre CA. Clinical correlates of obsessive compulsive disorder in children and adolescents referred to specialized and non-specialized clinical settings. Depress Anxiety. 2000; 11(4):163-8.
      View in: PubMed
    85. Spencer T, Biederman M, Coffey B, Geller D, Wilens T, Faraone S. The 4-year course of tic disorders in boys with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999 Sep; 56(9):842-7.
      View in: PubMed
    86. Spencer T, Biederman J, Harding M, O'Donnell D, Wilens T, Faraone S, Coffey B, Geller D. Disentangling the overlap between Tourette's disorder and ADHD. J Child Psychol Psychiatry. 1998 Oct; 39(7):1037-44.
      View in: PubMed
    87. Coffey BJ, Miguel EC, Biederman J, Baer L, Rauch SL, O'Sullivan RL, Savage CR, Phillips K, Borgman A, Green-Leibovitz MI, Moore E, Park KS, Jenike MA. Tourette's disorder with and without obsessive-compulsive disorder in adults: are they different? J Nerv Ment Dis. 1998 Apr; 186(4):201-6.
      View in: PubMed
    88. Geller D, Biederman J, Jones J, Park K, Schwartz S, Shapiro S, Coffey B. Is juvenile obsessive-compulsive disorder a developmental subtype of the disorder? A review of the pediatric literature. J Am Acad Child Adolesc Psychiatry. 1998 Apr; 37(4):420-7.
      View in: PubMed
    89. Coffey BJ, Park KS. Behavioral and emotional aspects of Tourette syndrome. Neurol Clin. 1997 May; 15(2):277-89.
      View in: PubMed
    90. Miguel EC, Baer L, Coffey BJ, Rauch SL, Savage CR, O'Sullivan RL, Phillips K, Moretti C, Leckman JF, Jenike MA. Phenomenological differences appearing with repetitive behaviours in obsessive-compulsive disorder and Gilles de la Tourette's syndrome. Br J Psychiatry. 1997 Feb; 170:140-5.
      View in: PubMed
    91. Miguel EC, Coffey BJ, Baer L, Savage CR, Rauch SL, Jenike MA. Phenomenology of intentional repetitive behaviors in obsessive-compulsive disorder and Tourette's disorder. J Clin Psychiatry. 1995 Jun; 56(6):246-55.
      View in: PubMed
    92. Coffey BJ, Miguel EC, Savage CR, Rauch SL. Tourette's disorder and related problems: a review and update. Harv Rev Psychiatry. 1994 Sep-Oct; 2(3):121-32.
      View in: PubMed
    93. Coffey B, Frazier J, Chen S. Comorbidity, Tourette syndrome, and anxiety disorders. Adv Neurol. 1992; 58:95-104.
      View in: PubMed
    94. Rosenthal SH, Porter KA, Coffey B. Pain insensitivity in schizophrenia. Case report and review of the literature. Gen Hosp Psychiatry. 1990 Sep; 12(5):319-22.
      View in: PubMed
    95. Coffey BJ. Anxiolytics for children and adolescents: traditional and new drugs. J Child Adolesc Psychopharmacol. 1990; 1(1):57-83.
      View in: PubMed
    96. Coffey B, Shader RI, Greenblatt DJ. Pharmacokinetics of benzodiazepines and psychostimulants in children. J Clin Psychopharmacol. 1983 Aug; 3(4):217-25.
      View in: PubMed
    Coffey's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067